
CAS 1945950-21-9
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 Produkte.
1-[(1,3-Dimethyl-1H-pyrazol-5-yl)methyl]-1,2,3,4-tetrahydro-N-(1-methylcyclopropyl)-3-[(2-methyl-5-thiazolyl)methyl]-2,4-dioxo-6-quinazolinesulfonamide
CAS:Formel:C23H26N6O4S2Reinheit:98%Farbe und Form:SolidMolekulargewicht:514.6203Ref: IN-DA01ENKB
1mg186,00€5mg246,00€10mg545,00€25mg639,00€50mgNachfragen100mgNachfragen200mgNachfragenPARG Inhibitor PDD00017273
CAS:Formel:C23H26N6O4S2Reinheit:≥ 98.0%Farbe und Form:White to yellow or beige powderMolekulargewicht:514.62PDD00017273
CAS:<p>PDD00017273 is a radiosensitizing PARG) inhibitor with antitumor or activity for the study of epithelial ovaries.</p>Formel:C23H26N6O4S2Reinheit:99.14% - 99.21%Farbe und Form:SolidMolekulargewicht:514.621-[(1,3-Dimethyl-1H-pyrazol-5-yl)methyl]-1,2,3,4-tetrahydro-N-(1-methylcyclopropyl)-3-[(2-methyl-5-thiazolyl)methyl]-2,4-dioxo-6-quinazolinesulfonamide
CAS:Reinheit:95%Molekulargewicht:514.6199951PDD 00017273
CAS:<p>PDD 00017273 is a monoclonal antibody that targets the adenosine diphosphate-ribose (ADP-ribose) termini of cancer cells. It binds to the ADP-ribose termini and prevents them from being labeled with monomers, which are necessary for DNA synthesis. PDD 00017273 has been shown to specifically bind to human cancers, including breast, prostate, lung, colorectal, leukemia, and lymphoma. The drug has been shown to produce tumor shrinkage in animal models and is currently in clinical trials for treatment of human cancers. 1) 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is an anti-tuberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding</p>Formel:C23H26N6O4S2Reinheit:Min. 95%Molekulargewicht:514.62 g/mol






